Welcome to our new web site!
To give our readers a chance to experience all that our new website has to offer, we have made all content freely avaiable, through October 1, 2018.
During this time, print and digital subscribers will not need to log in to view our stories or e-editions.
(BPT) - For him, it’s personal. In 2016 Milton “Todd” Ault III founded early clinical-stage biopharmaceutical company Alzamend Neuro with the mission of finding a cure for Alzheimer’s. Having witnessed the suffering of several family members with the disease and aware that little progress has been made toward treatment since Alzheimer’s discovery almost 100 years ago, Ault is committed to fast-tracking a cure. Coupling private sector investment with an Operation Warp Speed method to catalyze Big Pharma into action, Ault is working with proven Wall Street investors to raise funds and bring peace and resolution to patients and their families.